The extinguished BEACON of bardoxolone: not a Monday morning quarterback story. - sprookjes - yvandenbroek - TriplyDB

The extinguished BEACON of bardoxolone: not a Monday morning quarterback story.

The extinguished BEACON of bardoxolone: not a Monday morning quarterback story.

http://www.wikidata.org/entity/Q37050229

about

Chemical tuning enhances both potency toward nrf2 and in vitro therapeutic index of triterpenoids Role of Nuclear Factor Erythroid 2-Related Factor 2 in Diabetic Nephropathy.The Keap1-Nrf2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases.Slowing progression of chronic kidney disease Identification and quantification of the basal and inducible Nrf2-dependent proteomes in mouse liver: biochemical, pharmacological and toxicological implications Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties.The emerging role of the Nrf2-Keap1 signaling pathway in cancer The Nrf2 pathway in the progression of renal disease.Key pathways in renal disease progression of experimental diabetes.The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update.Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors.

P2860

Q28391638-74B5DB6F-F13D-4B73-82AE-DA40EAA12B68 Q33645497-C4336DE6-3330-4C89-92CB-CEFD5FB88550 Q33659621-73C75422-5021-43EE-B57E-829F825B52D5 Q33873241-554B5591-980D-47DE-8BED-B77FDB1E2717 Q33970540-A961F060-EA83-43D2-93D1-F843D084CB0D Q34415403-6BEE7B3E-E236-474A-A25C-FC8D5042DA4F Q37271797-4AD7A332-3D5F-49FE-BAD7-12C6ED67A55C Q38114031-CB25BC3D-F8A6-4E29-89F5-94B9C55CF6E2 Q38553926-C5B963DC-8EA8-4EF8-862F-BC5B2287B27B Q38837451-35ED35AD-CC76-454B-89E2-108CF8B697AF Q41634246-9A44CF58-598E-4F98-87F3-0F3FB68C15CD

P2860

The extinguished BEACON of bardoxolone: not a Monday morning quarterback story.

http://www.wikidata.org/entity/Q37050229

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 February 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The extinguished BEACON of bardoxolone: not a Monday morning quarterback story.

@en

The extinguished BEACON of bardoxolone: not a Monday morning quarterback story.

@nl

type

label

The extinguished BEACON of bardoxolone: not a Monday morning quarterback story.

@en

The extinguished BEACON of bardoxolone: not a Monday morning quarterback story.

@nl

prefLabel

The extinguished BEACON of bardoxolone: not a Monday morning quarterback story.

@en

The extinguished BEACON of bardoxolone: not a Monday morning quarterback story.

@nl

P1433

Q37050229-EA11E7E5-F6F1-43B5-A206-AC724220D914

P1476

Q37050229-EBC75407-6C3E-48BB-BCDF-0099D6C1719A

P2093

Q37050229-FFAF98EF-50F4-434E-B178-CF39AE835FE1

P2860

Q37050229-09A02811-A67C-4DDE-9D35-100580AED5B4

Q37050229-0B4FD63E-2E7B-43D8-A827-00A137BB3F77

Q37050229-1630C272-2D44-497F-914B-5813C5FDA35F

Q37050229-1CE724D6-2FAE-4618-B6BB-82F1C67DDE49

Q37050229-315589B5-3B47-4D95-9122-80AB4EF2238B

Q37050229-34A9F6D3-D782-4349-8E0F-115B58E67817

Q37050229-43E7C213-BEB6-4C00-BBAC-2640FEE22CAF

Q37050229-443756BF-2B74-4215-8524-3C86B4E1A44B

Q37050229-6E758212-73E6-43DB-912B-93CB1471EB0F

Q37050229-9265C205-417D-4791-8C70-2206BE126618

P304

Q37050229-B7EB15B0-3372-4BFA-AA8E-138C44298757

P31

Q37050229-0c93a8cb-70e5-4f11-ad66-3629125b84cc

Q37050229-D503CD2A-E013-4195-A3B8-A3AC82CE917A

P356

Q37050229-DE6EE770-ABA7-458E-9455-22C8D5B9FEBD

P433

Q37050229-7CD886E9-F8B0-4808-94A9-D7EAC00BC4B5

P478

Q37050229-A46DB52D-2903-4D4A-8B5E-87DBFDF05907

P50

Q37050229-4DABFE0B-753A-40D6-AAD2-965C381CA13D

P577

Q37050229-5719AD36-DC80-4965-A28B-58E14EBC77C8

P5875

Q37050229-DF4EB4AC-C40A-4BFE-9927-8C04F48A03D1

P698

Q37050229-A0C86B45-8E7C-4FD3-9494-6533B0BEC4CA

P932

Q37050229-7A42DF49-29D6-4EEC-892A-84C64E1496FF

P356

P1433

American Journal of Nephrology

P1476

The extinguished BEACON of bardoxolone: not a Monday morning quarterback story.

@en

P2093

John A Tayek

http://www.w3.org/2001/XMLSchema#string

P2860

Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature.

Urinary creatinine excretion rate and mortality in persons with coronary artery disease: the Heart and Soul Study

Bardoxolone methyl and kidney function in CKD with type 2 diabetes.

The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis.

Mid-arm muscle circumference and quality of life and survival in maintenance hemodialysis patients

Novel equations to estimate lean body mass in maintenance hemodialysis patients

Mortality prediction by surrogates of body composition: an examination of the obesity paradox in hemodialysis patients using composite ranking score analysis

Bardoxolone methyl decreases megalin and activates nrf2 in the kidney.

Renal effects of prostaglandin A1 in patients with essential hypertension.

Rationale and trial design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON).

P304

208-211

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000346950

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P50

Kamyar Kalantar-Zadeh

P577

2013-02-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235881035

http://www.w3.org/2001/XMLSchema#string

P698

23466901

http://www.w3.org/2001/XMLSchema#string

P932

3725304

http://www.w3.org/2001/XMLSchema#string